• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tissue plasminogen activating factor assisted removal of subretinal hemorrhage.

作者信息

Peyman G A, Nelson N C, Alturki W, Blinder K J, Paris C L, Desai U R, Harper C A

机构信息

LSU Eye Center, Louisiana State University Medical Center School of Medicine, New Orleans.

出版信息

Ophthalmic Surg. 1991 Oct;22(10):575-82.

PMID:1961614
Abstract

We used tissue plasminogen activator (tPA) to aid in the surgical evacuation of subretinal hemorrhages. Subretinal hemorrhage secondary to a ruptured retinal macroaneurysm was treated in two patients. The surgical technique involved using a micropipette to fashion a small retinotomy through which tPA was injected into the subretinal space and through which the dissolved clot was removed. Visual acuity improved from counts fingers to 20/50 in one patient and from counts fingers to 20/70 in the other. Three additional patients, with massive subretinal hemorrhages secondary to age-related macular degeneration, were similarly treated. In one, visual acuity improved from counts fingers to 20/400; in two others, visual acuity was stabilized; in the first patient, at 20/300, and in the second patient at 20/400. The use of tPA minimizes surgical manipulation of the sensory retina and greatly reduces the size of the retinotomy required for evacuation of subretinal blood.

摘要

相似文献

1
Tissue plasminogen activating factor assisted removal of subretinal hemorrhage.
Ophthalmic Surg. 1991 Oct;22(10):575-82.
2
Little effect of tissue plasminogen activator in subretinal surgery for acute hemorrhage in age-related macular degeneration.组织型纤溶酶原激活剂在年龄相关性黄斑变性急性出血性视网膜下手术中的作用甚微。
Ger J Ophthalmol. 1996 Nov;5(6):479-83.
3
Tissue plasminogen activator in the surgical management of subretinal haemorrhage.组织型纤溶酶原激活剂在视网膜下出血手术治疗中的应用
Aust N Z J Ophthalmol. 1994 Feb;22(1):59-63. doi: 10.1111/j.1442-9071.1994.tb01697.x.
4
Preoperative use of tissue plasminogen activator for large submacular hemorrhage.
Ophthalmic Surg Lasers. 1999 Mar;30(3):176-80.
5
Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.玻璃体切除术治疗黄斑变性引起的黄斑下出血:黄斑下出血/膜去除术与黄斑下组织纤溶酶原激活剂辅助气体置换术的比较
Trans Am Ophthalmol Soc. 2005;103:98-107; discussion 107.
6
A novel technique for extensive submacular hemorrhage using high-dose tissue plasminogen activator.一种使用大剂量组织型纤溶酶原激活剂治疗广泛的黄斑下出血的新方法。
Indian J Ophthalmol. 2024 Jun 1;72(6):921. doi: 10.4103/IJO.IJO_2295_23. Epub 2024 May 24.
7
Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.组织型纤溶酶原激活剂辅助玻璃体切除术治疗年龄相关性黄斑变性所致黄斑下出血
Indian J Ophthalmol. 2017 Jun;65(6):482-487. doi: 10.4103/ijo.IJO_129_16.
8
Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage.术前玻璃体内注射组织型纤溶酶原激活剂后行玻璃体视网膜切割术及周边视网膜切开术:一种用于引流大量视网膜下出血的改良手术方法
Br J Ophthalmol. 2007 Feb;91(2):193-8. doi: 10.1136/bjo.2006.101444. Epub 2006 Aug 17.
9
Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.玻璃体内注射组织型纤溶酶原激活剂及气体置换治疗黄斑下出血
Ophthalmology. 1999 Oct;106(10):1900-6; discussion 1906-7. doi: 10.1016/S0161-6420(99)90399-8.
10
Subretinal hemorrhage removal with multiple retinotomy sites in age-related macular degeneration.在年龄相关性黄斑变性中通过多个视网膜切开部位进行视网膜下出血清除术。
Ophthalmic Surg. 1994 Nov-Dec;25(10):723-5.

引用本文的文献

1
Pars plana vitrectomy with tissue plasminogen activator for traumatic submacular hemorrhage.玻璃体切割联合组织型纤溶酶原激活剂治疗外伤性黄斑下出血。
Int J Ophthalmol. 2025 Sep 18;18(9):1797-1802. doi: 10.18240/ijo.2025.09.22. eCollection 2025.
2
Thrombolytic activity of recombinant tissue-type plasminogen activator (rtPA) in in-vitro model for subretinal hemorrhages.重组组织型纤溶酶原激活剂(rtPA)在视网膜下出血体外模型中的溶栓活性。
Int Ophthalmol. 2025 May 3;45(1):164. doi: 10.1007/s10792-025-03545-y.
3
Comparison Between Intravitreal Anti-Vascular Endothelial Growth Factor Monotherapy and Vitrectomy in Age-Related Macular Degeneration with Large Submacular Hemorrhages.
玻璃体内抗血管内皮生长因子单药治疗与玻璃体切除术治疗伴有大量黄斑下出血的年龄相关性黄斑变性的比较
J Clin Med. 2025 Feb 22;14(5):1477. doi: 10.3390/jcm14051477.
4
High-efficiency base editing in the retina in primates and human tissues.灵长类动物视网膜和人体组织中的高效碱基编辑
Nat Med. 2025 Feb;31(2):490-501. doi: 10.1038/s41591-024-03422-8. Epub 2025 Jan 8.
5
Submacular hemorrhage: My personal journey to the goal.黄斑下出血:我通往目标的个人历程。
Graefes Arch Clin Exp Ophthalmol. 2025 Apr;263(4):901-908. doi: 10.1007/s00417-024-06671-y. Epub 2024 Oct 31.
6
Real-world outcomes and complications of different surgical approaches for significant submacular haemorrhages.不同手术方法治疗显著黄斑下出血的真实世界结局和并发症。
Indian J Ophthalmol. 2023 May;71(5):2045-2052. doi: 10.4103/ijo.IJO_1987_22.
7
Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage.眼内抗血管内皮生长因子单药治疗伴黄斑下出血的年龄相关性黄斑变性。
Sci Rep. 2023 Apr 7;13(1):5688. doi: 10.1038/s41598-023-32874-0.
8
Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series.经平坦部玻璃体切除术联合视网膜下组织型纤溶酶原激活剂治疗大型渗出性黄斑下出血:病例系列。
BMC Ophthalmol. 2022 Oct 27;22(1):411. doi: 10.1186/s12886-022-02639-w.
9
Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm.玻璃体切割术联合视网膜下注射组织型纤溶酶原激活剂治疗年龄相关性黄斑变性或大动脉瘤继发黄斑下出血后的视力预后
J Ophthalmol. 2021 Dec 30;2021:3160963. doi: 10.1155/2021/3160963. eCollection 2021.
10
Subretinal Injection of Recombinant Tissue Plasminogen Activator and Gas Tamponade to Displace Acute Submacular Haemorrhages Secondary to Age-Related Macular Degeneration.视网膜下注射重组组织型纤溶酶原激活剂联合气体填塞治疗年龄相关性黄斑变性继发急性黄斑下出血
Clin Ophthalmol. 2021 Aug 28;15:3649-3659. doi: 10.2147/OPTH.S324091. eCollection 2021.